Just an hour of weekly walking staves off disability
All brisk walking, even short walks, help prevent disability in older adults with osteoarthritis CHICAGO --- Just one hour a week of brisk walking --...
NEWS INDEX
New evidence about why clear margins in breast cancer surgery are such good news
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (April 1, 2019) - When a breast cancer tumor is removed with no signs of cancer...
New glioblastoma vaccine shows promising results in phase Ib clinical trial
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial. (PHILADELPHIA) - Glioblastoma is the most...
CD40 combination therapy can shrink pancreatic tumors
Study results to be presented during a plenary session at AACR Annual Meeting ATLANTA - A new combination of immunotherapy and chemotherapy for pancreatic cancer...
Excess body weight before 50 is associated with higher risk of dying from pancreatic cancer
ATLANTA --Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk than excess weight at older ages, according to results...
Pancreatic Cancer Collective funds two AI teams to identify high-risk populations
Computational tools seek to identify pancreatic cancer earlier, provide more opportunities for timely, effective treatmentsCredit: Pancreatic Cancer Collective (ATLANTA - March 30, 2019) - The...
Immunotherapy combination effective for patients with rare neuroendocrine cancer
Credit: Hope Foundation for Cancer Research A combination of two common immunotherapy drugs shrinks rare, aggressive neuroendocrine tumors, according to new research results presented at...
Adding savolitinib to osimertinib beneficial for certain pretreated lung cancer patients
ATLANTA -- Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who had EGFR-mutant non-small cell lung...
Immune checkpoint inhibitor combo efficacious for patients with neuroendocrine carcinoma
ATLANTA -- A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit among patients with rare, high-grade neuroendocrine...
HER2-targeted CAR T-cell therapy shows promising antitumor activity in patients with sarcoma
ATLANTA -- A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was found to be safe and...
Mesothelin-targeted CAR T-cell therapy shows early promise in patients with solid tumors
ATLANTA -- A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major toxicity and had antitumor activity in...
Fish slime: An untapped source of potential new antibiotics
ORLANDO, Fla., March 31, 2019 -- As current antibiotics dwindle in effectiveness against multidrug-resistant pathogens, researchers are seeking potential replacements in some unlikely places. Now...
Stunning discovery offers glimpse of minutes following ‘dinosaur-killer’ Chicxulub impact
LAWRENCE -- A study to be published Monday in the Proceedings of the National Academy of Sciences offers a scientific first: a detailed snapshot of...
Gastrointestinal complaints in children could signal future mental health problem
A Columbia-led study finds adversity-induced disruptions in the body's gut microbes influence are linked to changes in brain function A Columbia University study has found...
Mount Sinai and Hasso Plattner Institute launch new institute for digital health
Credit: Mount Sinai Health System The Mount Sinai Health System (MSHS) and the Hasso Plattner Institute (HPI) today announced an affiliation that brings together industry...